Theratechnologies Operating Cycle 2011-2026 | THTX

Annual Operating Cycle Theratechnologies

2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-	-	-	-	-	-	456	738	1.21 K	1.71 K	1.07 K	-	92.2 K

All numbers in USD currency

Maximum	Minimum	Average
92.2 K	456	16.2 K

Issuer	Operating Cycle	Price	% 24h	Market Cap	Country
ACADIA Pharmaceuticals ACAD	332	$ 22.57	0.04 %	$ 3.74 B	USA
Acorda Therapeutics ACOR	394	-	-24.86 %	$ 820 K	USA
Akebia Therapeutics AKBA	210	$ 1.41	-1.4 %	$ 363 M	USA
I-Mab IMAB	271	-	-	$ 866 M	China
Alexion Pharmaceuticals, Inc. ALXN	12.8	-	-	$ 40.3 B	USA
Midatech Pharma plc MTP	245	-	-18.52 %	$ 27.3 M	Britain
EyeGate Pharmaceuticals, Inc. EYEG	32	-	-1.52 %	$ 24.7 M	USA
Aytu BioScience AYTU	360	$ 2.56	-3.76 %	$ 16.1 M	USA
AstraZeneca PLC AZN	206	-	-	$ 96.9 B	Britain
Advaxis ADXS	88.1	-	-9.65 %	$ 45.9 M	USA
Amphastar Pharmaceuticals AMPH	237	$ 20.87	2.3 %	$ 976 M	USA
Aquestive Therapeutics AQST	223	$ 4.17	-0.24 %	$ 446 M	USA
Ayala Pharmaceuticals AYLA	61.7	-	-	$ 7.46 M	Israel
Институт стволовых клеток человека ISKJ	104	-	-	-	Russia
Arcutis Biotherapeutics ARQT	291	$ 24.57	-0.16 %	$ 3.13 B	USA
BeiGene, Ltd. BGNE	52.6	-	0.49 %	$ 251 B	Cayman-islands
Aeterna Zentaris AEZS	115	-	5.93 %	$ 314 M	Canada
AgeX Therapeutics AGE	186	-	-10.17 %	$ 12.2 K	USA
AIkido Pharma AIKI	17.9	-	1.93 %	$ 17.4 M	USA
Avid Bioservices CDMO	148	-	-	$ 789 M	USA
Cidara Therapeutics CDTX	2.26 K	-	-	$ 1.41 B	USA
Celldex Therapeutics CLDX	321	$ 33.62	3.73 %	$ 2.23 B	USA